neuroblastoma

Our St. Baldrick’s Foundation Research Outcomes blogs highlight examples of the progress your donations are supporting. This quarterly edition focuses on a new FDA approval for neuroblastoma, strategies to improve T cell functioning, understanding why some kids with medulloblastoma get sicker, and how secondary cancers increase the likelihood of future heart problems.

Thank you for making this research possible.

Read more »

Ambassador Julianna rocking a very cute outfit.

Julianna (a.k.a. Juju) is always on the go. This five-year-old is obsessed with Jack Sparrow, loves swimming, bike riding, dancing, baby dolls, dressing up, playing doctor, school, and church, especially worship music. She expends her energy at dance and cheer camp, and is excited to start gymnastics soon. Above all she cherishes time with her mom and dad, Courtney and Ryan, and big brothers, Hayden and Colbe.

Read more »

St. Baldrick’s Ambassadors represent the more than 400,000 kids worldwide who are diagnosed with cancer each year. Ambassadors come from diverse geographic areas, ages, diseases, and treatment statuses. Their stories highlight the importance of supporting the best childhood cancer research so all kids diagnosed can live long, healthy, productive, and happy lives.

Every child is so much more than a cancer diagnosis. Each has their own unique personality, gifts, and talents. Read on to learn more about these remarkable kids.

Read more »

Our St. Baldrick’s Foundation Research Outcomes blogs highlight examples of the progress your donations are supporting. This quarterly edition focuses on understanding how rhabdomyosarcoma grows, using immunotherapy to treat pediatric brain tumors and relapsed neuroblastoma, as well as research to understand the experiences of adolescents and young adults being treated for advanced pediatric cancer.

Thank you for making research – and hope — possible.

Read more »

This quarterly edition of the St. Baldrick’s Foundation Research Outcomes features work focused on fighting neuroblastoma, rhabdomyosarcoma, and acute lymphoblastic leukemia as well as research to improve identification of survivors at risk for cardiotoxicity.

Thank you for making these outcomes – and more – possible.

Read more »

This quarterly edition of the St. Baldrick’s Foundation Research Outcomes features research made possible by you to reduce late effects, improve survival for relapsed T-ALL, increase NK (natural killer) cells levels in cancer patients, and share valuable data.

Thank you for making research possible.

Read more »

His mom calls him “an old soul.” This almost three-year-old little boy feels deeply and loves immensely — grown-up strengths that are carrying him through hard days in and out of the hospital as he faces off with cancer. This is Bodie.

Read more »

As we close a difficult year, we reflect on lessons shared by childhood cancer patients and survivors who have faced adversity with grace, courage, and resilience. From their words, come some messages worth remembering now.

Sarah Swaim, age 31, two-time leukemia survivor & advocate

Read more »

Luke is blazing a trail with no roadmap. Now 12 years old, he’s been fighting high-risk neuroblastoma since he was 5, with three relapses. He’s constantly relying on the kind of cutting-edge research you support through St. Baldrick’s to find the next new treatment – the one that will make him cancer-free for good.

Read more »

Susan L. Cohn, M.D., chair of the St. Baldrick’s Scientific Advisory Committee and world renowned neuroblastoma expert, explains what neuroblastoma is and how St. Baldrick’s research is contributing to better outcomes for patients.

Read more »